Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023;61(2):123-129.
doi: 10.5114/reum/163090. Epub 2023 May 10.

VEXAS syndrome: a newly discovered systemic rheumatic disorder

Affiliations
Review

VEXAS syndrome: a newly discovered systemic rheumatic disorder

Eugenisz J Kucharz. Reumatologia. 2023.

Abstract

VEXAS syndrome is an adult-onset autoinflammatory disease associated with hematologic symptoms. The disease affects primarily males, and leads to death of a significant proportion of the patients. VEXAS syndrome is caused by a somatic mutation of the UBA1 gene in hematopoietic progenitor cells. The clinical picture of the syndrome consists of a number of organ manifestations including those akin to rheumatic diseases, arthritis, myalgia, vasculitis and chondritis.

Keywords: UBA1 gene; autoinflammatory diseases; somatic mutations.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Similar articles

Cited by

  • Painful Diplopia as an Initial Presentation of VEXAS Syndrome.
    Zewar A, Zollinger-Read C, Dunkley L, Jefferis JM. Zewar A, et al. Neuroophthalmology. 2024 Mar 12;48(5):360-363. doi: 10.1080/01658107.2024.2324387. eCollection 2024. Neuroophthalmology. 2024. PMID: 39145321 Free PMC article.
  • VEXAS: A review of current understandings and emerging treatment strategies.
    Holden R, Jeelal Y, McLean-Tooke A, Pathmanathan K, Nolan D. Holden R, et al. Front Immunol. 2025 Jul 28;16:1644404. doi: 10.3389/fimmu.2025.1644404. eCollection 2025. Front Immunol. 2025. PMID: 40791602 Free PMC article. Review.
  • Mechanisms of hematopoietic clonal dominance in VEXAS syndrome.
    Molteni R, Fiumara M, Campochiaro C, Alfieri R, Pacini G, Licari E, Tomelleri A, Diral E, Varesi A, Weber A, Quaranta P, Albano L, Gaddoni C, Basso-Ricci L, Stefanoni D, Alessandrini L, Degl'Innocenti S, Sanvito F, Bergonzi GM, Annoni A, Panigada M, Cantoni E, Canarutto D, Xie SZ, D'Alessandro A, Di Micco R, Aiuti A, Ciceri F, De Luca G, Dagna L, Matucci-Cerinic M, Merelli I, Cenci S, Scala S, Cavalli G, Naldini L, Ferrari S. Molteni R, et al. Nat Med. 2025 Jun;31(6):1911-1924. doi: 10.1038/s41591-025-03623-9. Epub 2025 Apr 7. Nat Med. 2025. PMID: 40195449 Free PMC article.

References

    1. Beck DB, Ferrada MA, Sikora KA, et al. . Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease. N Engl J Med 2020; 383: 2628–2638, DOI: 10.1056/NEJMoa2026834. - DOI - PMC - PubMed
    1. Vitale A, Caggiano V, Bimonte A. VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases. Intern Emerg Med 2023; 18: 711–722, DOI: 10.1007/s11739-023-03193-z. - DOI - PMC - PubMed
    1. Templé M, Kosmider O. VEXAS syndrome: a novelty in MDS landscape. Diagnostics (Basel) 2022; 12: 1590, DOI: 10.3390/diagnostics12071590. - DOI - PMC - PubMed
    1. Templé M, Duroyon E, Croizier C, et al. . Atypical slice site mutations causing VEXAS syndrome. Rheumatology (Oxford) 2021; 60: e435-e437, DOI: 10.1093/rheumatology/keab524. - DOI - PubMed
    1. Stiburkova B, Pavelcova K, Belickova M, et al. . Novel somatic UBA1 variant in a patient with VEXAS syndrome. Arthritis Rheumatol 2023, DOI: 10.1002/art.42471 [Online ahead of print]. - DOI - PMC - PubMed

LinkOut - more resources